USA ends border seizures of mailed drugs

15 October 2006

The US Customs and Border Protection agency has ceased the seizure of prescription drugs that are mailed from Canadian pharmacies to US residents, effective from October 9. The news comes shortly after the US Congress voted to authorize the transportation across the border of three months' supply of Canadian-supplied drugs per trip (Marketletter October 2).

The legislation excluded drug purchases via the Internet and where a Canadian doctor had not physically examined the patient, in addition to a US physician's prescription. However, the new development means the law enforcement effort will restrict itself to targeting counterfeit drugs.

An e-mail sent from the US Customs agency to some members of Congress said that blanket seizures would end on October 9 and that random packages would be examined for fake drugs. It appears that the move follows widespread criticism from pressure groups such as the American Association for Retired Persons that the seizure policy, which began in November last year, deprived "thousands of American seniors of their drugs" and protected the "high prices charged by US pharmaceutical companies," according to the Wall Street Journal.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight